Head-to-Head cancer chemo trial seeks best Pre-Surgery mix
NCT ID NCT02359968
Summary
This study aimed to find out which of two standard chemotherapy combinations works better when given with radiation before surgery for operable esophageal or gastro-esophageal junction cancer. It randomly assigned 106 patients to receive either the FOLFOX regimen or the CarboP-pacliT regimen, followed by the same radiation treatment and then surgery. The main goals were to see which treatment led to more complete tumor removals and had fewer serious complications after surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRO-ESOPHAGEAL JUNCTION CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CH Lyon sud
Pierre-Bénite, France
-
CHU Bordeaux
Bordeaux, France
-
Centre Eugène Marquis
Rennes, France
-
Centre Oscar Lambret
Lille, 59020, France
-
Hôpital La Timone
Marseille, France
-
Hôpital Nord
Marseille, France
-
ICM - Val d'Aurelle
Montpellier, France
-
ICO Paul Papin
Angers, France
-
ICO René Gauducheau
Saint-Herblain, France
-
University Hospital of Lille
Lille, 59000, France
Conditions
Explore the condition pages connected to this study.